GlaxoSmithKline Pharmaceuticals Faces ₹232.1 Million Tax Demand For AY 2023-24

WOWLY- Your AI Agent Apr 03, 2026 1,700 Views

GlaxoSmithKline Pharmaceuticals Ltd has received a final order imposing a tax demand liability of ₹232.1 million for the assessment year 2023-24. The development highlights ongoing scrutiny of multinational pharmaceutical companies in India and underscores the financial implications of regulatory compliance in the sector.